143 related articles for article (PubMed ID: 15505932)
1. Everyone should watch glycosated hemoglobin and blood sugar levels, not just diabetics, research says.
Levenson D
Rep Med Guidel Outcomes Res; 2004 Oct; 15(20):1-2, 5-6. PubMed ID: 15505932
[No Abstract] [Full Text] [Related]
2. [Intensive blood glucose control in type 2 diabetes: it is confirmed that the risk of severe hypoglycemias increases].
Steurer J
Praxis (Bern 1994); 2012 Apr; 101(9):617-8. PubMed ID: 22535460
[No Abstract] [Full Text] [Related]
3. [Postprandial glycemia in diabetes patients: assessing this indicator].
Letonturier P
Presse Med; 2006 Dec; 35(12 Pt 1):1855-6. PubMed ID: 17205659
[No Abstract] [Full Text] [Related]
4. Cardiovascular disease (CVD) limbo: how soon and low should we go to prevent CVD in diabetes?
Maahs DM
Diabetes Technol Ther; 2012 Jun; 14(6):449-52. PubMed ID: 22472062
[No Abstract] [Full Text] [Related]
5. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
Cavalot F
Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
[TBL] [Abstract][Full Text] [Related]
6. [Near-norm blood sugar regulation in diabetes. Myocardial infarct rate halved].
MMW Fortschr Med; 2005 Sep; 147(35-36):4-5. PubMed ID: 16180560
[No Abstract] [Full Text] [Related]
7. Glycemic control and cardiovascular disease: what's a doctor to do?
Kishore P; Kim SH; Crandall JP
Curr Diab Rep; 2012 Jun; 12(3):255-64. PubMed ID: 22467273
[TBL] [Abstract][Full Text] [Related]
8. Summaries for patients. The relationship between blood sugar control and cardiovascular disease in patients with diabetes.
Ann Intern Med; 2004 Sep; 141(6):I21. PubMed ID: 15381537
[No Abstract] [Full Text] [Related]
9. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
Füchtenbusch M; Hummel M
MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157
[No Abstract] [Full Text] [Related]
10. Glycemic control and CAD risk: a heretical thought.
Orchard TJ
Diabetes Care; 1999 Jul; 22(7):1220. PubMed ID: 10388997
[No Abstract] [Full Text] [Related]
11. [A critical appraisal of the European guidelines on diabetes, pre-diabetes and cardiovascular diseases].
Miccoli R
G Ital Cardiol (Rome); 2014 Jun; 15(6):350-4. PubMed ID: 25072420
[No Abstract] [Full Text] [Related]
12. Intensified glucose control in type 2 diabetes--whose agenda?
Yudkin JS; Richter B; Gale EA
Lancet; 2011 Apr; 377(9773):1220-2. PubMed ID: 21093903
[No Abstract] [Full Text] [Related]
13. It's time for a standard glucose report from CGM.
Kaufman FR
Diabetes Technol Ther; 2013 Mar; 15(3):197. PubMed ID: 23451791
[No Abstract] [Full Text] [Related]
14. Diabetes. Paradoxical effects of tightly controlled blood sugar.
Taubes G
Science; 2008 Oct; 322(5900):365-7. PubMed ID: 18927369
[No Abstract] [Full Text] [Related]
15. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
[No Abstract] [Full Text] [Related]
16. Should the target A1C level be less than 7 percent? Yes: This should be the target for most patients.
Peterson K
Am Fam Physician; 2012 Dec; 86(12):1-2. PubMed ID: 23316992
[No Abstract] [Full Text] [Related]
17. [Intensive blood glucose reduction: yes or no?].
Bischoff A
MMW Fortschr Med; 2015 Mar; 157(4):18-9. PubMed ID: 25743962
[No Abstract] [Full Text] [Related]
18. Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.
Skriver MV; Støvring H; Kristensen JK; Charles M; Sandbæk A
Diabetologia; 2012 Sep; 55(9):2361-70. PubMed ID: 22736395
[TBL] [Abstract][Full Text] [Related]
19. Glycosylated hemoglobin: finally ready for prime time as a cardiovascular risk factor.
Gerstein HC
Ann Intern Med; 2004 Sep; 141(6):475-6. PubMed ID: 15381522
[No Abstract] [Full Text] [Related]
20. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.
Yoshiuchi K; Matsuhisa M; Katakami N; Nakatani Y; Sakamoto K; Matsuoka T; Umayahara Y; Kosugi K; Kaneto H; Yamasaki Y; Hori M
Endocr J; 2008 Jul; 55(3):503-7. PubMed ID: 18445997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
